FILTER
FILTERED INTERVIEW RESULTS
Martin van Gemert
REGIONAL VICE PRESIDENT (AFRICA), MINCON
"A big change that is shaping the mining value chain in Africa is the proliferation of mining contractors and, specifically, local contractors, which we believe will bring enormous socioeconomic benefits."
Nishen Hariparsad
GENERAL MANAGER (TECHNOLOGY, INNOVATION, GLOBAL PRODUCT MANAGEMENT MARKETING), BME
"While there remains a place for the more traditional blasting methods – with their characteristic limitations – the Global trend is very much towards advanced blasting solutions."
Hadley Natus
CHAIRMAN, TANTALEX LITHIUM RESOURCES CORP
Tantalex Lithium Resources updates GBR on its various projects in DRC.
Errol Smart
CEO, ORION MINERALS
Orion Minerals outlines its strategy for developing copper and zinc projects in South Africa.
Catherine Warburton
MANAGING DIRECTOR, WARBURTON ATTORNEYS INC
"The firm specializes in the dynamic field of sustainability law, focusing on environmental law, energy law, mining law and policy, and occupational and mine health and safety law."
Mark Bristow
PRESIDENT AND CEO, BARRICK GOLD
Mark Bristow spoke with GBR about Barrick’s global operations and sustainability philosophy.
Deon de Kock
PRESIDENT, SUB-SAHARAN AFRICA, MIDDLE EAST & SOUTH ASIA, FLSMIDTH
FLSmidth is an international supplier of sustainable solutions and services to the global cement and mining industries.
Mxolisi Mgojo, Nombasa Tsengwa & Sakkie Swanepoel
CEO; CEO-DESIGNATE AND MANAGING DIRECTOR OF MINERALS & GROUP MANAGER MARKETING, EXXARO RESOURCES
Exxaro considers the role of coal as South Africa moves towards green energies.
Cobus Loots
CEO, PAN AFRICAN RESOURCES
Pan African Resources is a mid-tier African-focused gold producer listed in Johannesburg and on the AIM market in London.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
